Purple Biotech (XTAE:PPBT) Total Assets : ₪169.58 Mil (As of Dec. 2023)

View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech Total Assets?

Purple Biotech's Total Assets for the quarter that ended in Dec. 2023 was ₪169.58 Mil.

During the past 12 months, Purple Biotech's average Total Assets Growth Rate was 28.30% per year. During the past 3 years, the average Total Assets Growth Rate was 3.60% per year. During the past 5 years, the average Total Assets Growth Rate was 30.30% per year. During the past 10 years, the average Total Assets Growth Rate was 71.40% per year.

During the past 11 years, Purple Biotech's highest 3-Year average Total Assets Growth Rate was 310.60%. The lowest was 0.70%. And the median was 49.40%.

Total Assets is connected with ROA %. Purple Biotech's annualized ROA % for the quarter that ended in Dec. 2023 was -43.12%. Total Assets is also linked to Revenue through Asset Turnover. Purple Biotech's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Purple Biotech Total Assets Historical Data

The historical data trend for Purple Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Total Assets Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

56.34

320.79

268.71

209.09

169.58

Purple Biotech Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															209.09	203.19	183.74	173.30	169.58

Purple Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Purple Biotech's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	131.285	+	38.298
	=	169.58

Purple Biotech's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	131.285	+	38.298
	=	169.58

Purple Biotech (XTAE:PPBT) Total Assets Explanation

Total Assets is connected with ROA %.

Purple Biotech's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-73.924	/	( (173.297	+	169.583)	/ 2 )
	=	-73.924	/	171.44
	=	-43.12 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Purple Biotech's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (173.297	+	169.583)	/ 2 )
=	0	/	171.44
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Purple Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Purple Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (XTAE:PPBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

PPBT:USA 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.